Atlas Trials

Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study

Clinical trial NCT01813773 · COMPLETED

Trial details

NCT number
NCT01813773
Sponsor
Ophthalmic Consultants of Long Island
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2013-03-01
Primary completion
2016-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.